{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:40:49Z","timestamp":1785775249689,"version":"3.56.0"},"reference-count":39,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,20]]},"DOI":"10.20945\/2359-3997000000514","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T19:59:00Z","timestamp":1664222340000},"source":"Crossref","is-referenced-by-count":4,"title":["Risk predictors of advanced hepatic fibrosis in patients with nonalcoholic fatty liver disease \u2013 a survey in a university hospital in Brazil"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9979-3076","authenticated-orcid":false,"given":"Tha\u00eds Grecca","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-5269","authenticated-orcid":false,"given":"Luana Cavalcanti Dias","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2369-7686","authenticated-orcid":false,"given":"Fernanda Fernandes","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4785-667X","authenticated-orcid":false,"given":"Roberta Chaves","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"1","key":"key20220926155856_B1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.","journal-title":"Hepatology"},{"issue":"6","key":"key20220926155856_B2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-402.","journal-title":"J Hepatol"},{"issue":"5","key":"key20220926155856_B3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease","volume":"156","author":"Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(5):1264-81.e4.","journal-title":"Gastroenterology"},{"issue":"10290","key":"key20220926155856_B4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212-24.","journal-title":"Lancet"},{"issue":"7","key":"key20220926155856_B5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1.","journal-title":"Gastroenterology"},{"issue":"6","key":"key20220926155856_B6","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69(6):2672-82.","journal-title":"Hepatology"},{"issue":"5","key":"key20220926155856_B7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017;65(5):1557-65.","journal-title":"Hepatology"},{"issue":"9","key":"key20220926155856_B8","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467-74.","journal-title":"Am J Gastroenterol"},{"key":"key20220926155856_B9","volume-title":"Diretrizes Brasileiras de Obesidade","author":"Associa\u00e7\u00e3o Brasileira para o Estudo da Obesidade e da S\u00edndrome Metab\u00f3lica (Abeso)","year":"2016","unstructured":"Associa\u00e7\u00e3o Brasileira para o Estudo da Obesidade e da S\u00edndrome Metab\u00f3lica (Abeso). Diretrizes Brasileiras de Obesidade. S\u00e3o Paulo: Abeso; 2016."},{"issue":"2","key":"key20220926155856_B10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68(2):305-15.","journal-title":"J Hepatol"},{"issue":"4","key":"key20220926155856_B11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-54.","journal-title":"Hepatology"},{"issue":"6","key":"key20220926155856_B12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al.; APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317-25.","journal-title":"Hepatology"},{"issue":"3","key":"key20220926155856_B13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726-36.","journal-title":"Hepatology"},{"key":"key20220926155856_B14","volume-title":"ROC curves for continuous data","author":"Krzanowski","year":"2011","unstructured":"Krzanowski WJ, Hand DJ. ROC curves for continuous data. Boca Raton, FL: CRC\/Taylor and Francis\/Chapman & Hall; 2011."},{"issue":"3","key":"key20220926155856_B15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-45.","journal-title":"Biometrics"},{"issue":"2","key":"key20220926155856_B16","first-page":"1","article-title":"Atualiza\u00e7\u00e3o da Diretriz Brasileira de Dislipidemias e Preven\u00e7\u00e3o da Aterosclerose \u2013 2017","volume":"109","author":"Faludi","year":"2017","unstructured":"Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune A Neto, et al. Atualiza\u00e7\u00e3o da Diretriz Brasileira de Dislipidemias e Preven\u00e7\u00e3o da Aterosclerose \u2013 2017. Arq Bras Cardiol. 2017;109(2 Supl 1):1-76.","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"key20220926155856_B17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","unstructured":"Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705-25.","journal-title":"Gastroenterology"},{"key":"key20220926155856_B18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0102-86502006000700017","article-title":"Nonalcoholic fatty liver disease and obesity","volume":"21","author":"Salgado","year":"2006","unstructured":"Salgado J\u00fanior W, Santos JS, Sankarankutty AK, Silva Ode C. Nonalcoholic fatty liver disease and obesity. Acta Cir Bras. 2006;21 Suppl 1:72-8.","journal-title":"Acta Cir Bras"},{"issue":"4","key":"key20220926155856_B19","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology. 2019;70(4):1457-69.","journal-title":"Hepatology"},{"issue":"1","key":"key20220926155856_B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","unstructured":"Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, et al.; Nonalcoholic Steatohepatitis Clinical Research Network. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology. 2016;64(1):85-91.","journal-title":"Hepatology"},{"issue":"6","key":"key20220926155856_B21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","unstructured":"Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949-58.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"key20220926155856_B22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.","journal-title":"Hepatology"},{"issue":"1","key":"key20220926155856_B23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","unstructured":"Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis. 2012;32(1):22-9.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"key20220926155856_B24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy","volume":"3","author":"Zhang","year":"2015","unstructured":"Zhang QQ, Lu LG. Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy. J Clin Transl Hepatol. 2015;3(1):78-84.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"key20220926155856_B25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension","volume":"75","author":"Zhao","year":"2020","unstructured":"Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension. Hypertension. 2020;75(2):275-84.","journal-title":"Hypertension"},{"key":"key20220926155856_B26","doi-asserted-by":"crossref","first-page":"9127847","DOI":"10.1155\/2017\/9127847","article-title":"Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis","volume":"2017","author":"Toshikuni","year":"2017","unstructured":"Toshikuni N, Tsuchishima M, Fukumura A, Arisawa T, Tsutsumi M. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis. Gastroenterol Res Pract. 2017;2017:9127847.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"key20220926155856_B27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11894-008-0012-0","article-title":"Nonalcoholic fatty liver disease as a component of the metabolic syndrome","volume":"10","author":"Khashab","year":"2008","unstructured":"Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep. 2008;10(1):73-80.","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"key20220926155856_B28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44-52.","journal-title":"Hepatology"},{"issue":"8","key":"key20220926155856_B29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","unstructured":"Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25(8):883-9.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"key20220926155856_B30","first-page":"65","article-title":"Gamma glutamyl transferase \u2013 an underestimated marker for cardiovascular disease and the metabolic syndrome","volume":"23","author":"Neuman","year":"2020","unstructured":"Neuman MG, Malnick S, Chertin L. Gamma glutamyl transferase \u2013 an underestimated marker for cardiovascular disease and the metabolic syndrome. J Pharm Sci. 2020;23(1):65-74.","journal-title":"J Pharm Sci"},{"issue":"2","key":"key20220926155856_B31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","unstructured":"Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234-8.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"key20220926155856_B32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, Hammar U, St\u00e5l P, Hultcrantz R, et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol. 2017;67(6):1265-73.","journal-title":"J Hepatol"},{"issue":"2","key":"key20220926155856_B33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(2):389-97.e10.","journal-title":"Gastroenterology"},{"issue":"5","key":"key20220926155856_B34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2011;33(5):525-40.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"key20220926155856_B35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ; Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104-12.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"key20220926155856_B36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1665-2681(19)31004-X","article-title":"Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population","volume":"12","author":"P\u00e9rez-Guti\u00e9rrez","year":"2013","unstructured":"P\u00e9rez-Guti\u00e9rrez OZ, Hern\u00e1ndez-Rocha C, Candia-Balboa RA, Arrese MA, Ben\u00edtez C, Brizuela-Alc\u00e1ntara DC, et al. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. Ann Hepatol. 2013;12(3):416-24.","journal-title":"Ann Hepatol"},{"issue":"1","key":"key20220926155856_B37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2008.07.035","article-title":"Comparison of blood tests for liver fibrosis specific or not to NAFLD","volume":"50","author":"Cal\u00e8s","year":"2009","unstructured":"Cal\u00e8s P, Lain\u00e9 F, Boursier J, Deugnier Y, Moal V, Oberti F, et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol. 2009;50(1):165-73.","journal-title":"J Hepatol"},{"issue":"12","key":"key20220926155856_B38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis: A Review. JAMA. 2020;323(12):1175-83.","journal-title":"JAMA"},{"issue":"5","key":"key20220926155856_B39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71(5):1006-19.","journal-title":"Gut"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T19:59:43Z","timestamp":1664222383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/risk-predictors-of-advanced-hepatic-fibrosis-in-patients-with-nonalcoholic-fatty-liver-disease-a-survey-in-a-university-hospital-in-brazil\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":39,"alternative-id":["10.20945\/2359-3997000000514"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000514","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]}}}